Fonville Wealth Management’s AbbVie ABBV Stock Holding History

Fonville Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$383K	Buy	1,522 +117	+8%	+$25.2K	0.06%	107
2026 Q1	$306K	Buy	1,405 +1	+0.1%	+$222	0.06%	104
2025 Q4	$321K	Buy	1,404 +39	+3%	+$8.88K	0.07%	103
2025 Q3	$316K	Hold	1,365	–	–	0.07%	102
2025 Q2	$253K	Sell	1,365 -430	-24%	-$79.9K	0.06%	109
2025 Q1	$374K	Sell	1,795 -388	-18%	-$75.4K	0.11%	87
2024 Q4	$388K	Hold	2,183	–	–	0.13%	76
2024 Q3	$431K	Buy	2,183 +245	+13%	+$45.7K	0.15%	74
2024 Q2	$332K	Buy	1,938 +2	+0.1%	+$331	0.13%	77
2024 Q1	$353K	Hold	1,936	–	–	0.16%	71
2023 Q4	$300K	Buy	+1,936	New	+$282K	0.16%	73

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fonville Wealth Management's ABBV Position: Q2 2026 in Review

Fonville Wealth Management increased its AbbVie (ABBV) stake by 8.3% in Q2 2026, buying an estimated $25.2K and bringing the position to 1,522 shares worth $383K. The position accounts for 0.06% of the portfolio, ranked #107.

Fonville Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $431K in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fonville Wealth Management held 1,522 shares of AbbVie worth $383K as of Q2 2026.
Fonville Wealth Management bought 117 AbbVie shares in Q2 2026, an estimated $25.2K.
AbbVie made up 0.06% of Fonville Wealth Management's portfolio in Q2 2026, its #107 holding.
Fonville Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Fonville Wealth Management's AbbVie position peaked at $431K in Q3 2024.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fonville Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.